Michael E. Goldberg is David Mahoney Professor of Brain and Behavior in the departments of neuroscience, neurology, psychiatry and ophthalmology at Columbia University College of Physicians and Surgeons, director of the Mahoney-Keck Center for Brain and Behavior Research, and is an active clinical neurologist. His neuroscience research focuses on the physiological basis of cognitive processes such as visual attention, spatial perception and decision-making. He earned his M.D. from Harvard Medical School in 1968. From 1978 to 2001, Goldberg was a senior investigator at the Laboratory of Sensorimotor Research at the National Eye Institute in Bethesda, Maryland. He is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and an elected member of the National Academy of Sciences. He is a past president of the Society for Neuroscience, and now chair of the society’s Committee on Animals in Research.
Michael E. Goldberg
David Mahoney Professor of Brain and Behavior
Columbia University
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.